Severe Coronavirus Disease 2019 Infection in an Adolescent Patient After Hematopoietic Stem Cell Transplantation

Chest. 2020 Oct;158(4):e139-e142. doi: 10.1016/j.chest.2020.05.579.

Abstract

Infection with the severe acute respiratory syndrome coronavirus 2 causes severe acute lung injury in approximately 5% of infected adults, but few reports have been made of severe pediatric disease. We present an adolescent patient who contracted severe acute respiratory syndrome coronavirus 2 one week after a paternal haplo-identical hematopoietic stem cell transplant, with development of severe hyperferritinemic acute lung injury and macrophage activation-like syndrome. We present her case and a comparison of her laboratory data with those of a cohort of pediatric patients with coronavirus disease 2019 without severe disease.

Keywords: COVID-19; bone marrow transplant; macrophage activation-like syndrome; pediatric acute respiratory distress syndrome; pediatrics.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Betacoronavirus*
  • COVID-19
  • Coronavirus Infections / diagnosis*
  • Coronavirus Infections / etiology
  • Coronavirus Infections / therapy*
  • Female
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Humans
  • Myelodysplastic Syndromes / complications
  • Myelodysplastic Syndromes / therapy*
  • Pandemics
  • Pneumonia, Viral / diagnosis*
  • Pneumonia, Viral / etiology
  • Pneumonia, Viral / therapy*
  • SARS-CoV-2